Scarica l'app Stockscreener
29.79
9.40%
-3.09
Dopo l'orario di chiusura:
29.79
Precedente Chiudi:
$32.88
Aprire:
$30
Volume 24 ore:
1.77M
Relative Volume:
2.02
Capitalizzazione di mercato:
$1.90B
Reddito:
$13.05M
Utile/perdita netta:
$-60.54M
Rapporto P/E:
-25.68
EPS:
-1.16
Flusso di cassa netto:
$-37.82M
1 W Prestazione:
-7.57%
1M Prestazione:
+15.60%
6M Prestazione:
-46.11%
1 anno Prestazione:
-54.01%
Intervallo 1D:
$29.23
$31.39
Intervallo di 1 settimana:
$29.23
$33.97
Portata 52W:
$22.52
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
Nome
Janux Therapeutics Inc
Settore
Industria
Telefono
(858) 751-4493
Indirizzo
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Confronta JANX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
29.79 | 1.90B | 13.05M | -60.54M | -37.82M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-03 | Reiterato | BTIG Research | Buy |
| 2024-12-03 | Reiterato | H.C. Wainwright | Buy |
| 2024-11-22 | Iniziato | Leerink Partners | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Scotiabank | Sector Perform |
| 2024-03-21 | Iniziato | BTIG Research | Buy |
| 2024-03-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-06 | Iniziato | Wedbush | Outperform |
| 2022-11-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Janux Therapeutics Inc Borsa (JANX) Ultime notizie
Buy Rating for Janux Therapeutics Inc: Promising Clinical Trial Results and Positive Outlook for JANX007 - TipRanks
Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential - Yahoo Finance
Janux Therapeutics begins phase 1b trial for prostate cancer therapy By Investing.com - Investing.com India
Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates - Business Wire
Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Unknown Billionaire Phill Gross’ 10 Stock Picks with Huge Upside Potential - Insider Monkey
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
A new trading data show Janux Therapeutics Inc (JANX) is showing positive returns. - Sete News
Learn to Evaluate (JANX) using the Charts - news.stocktradersdaily.com
Trading Day Review: Janux Therapeutics Inc (JANX) Loses Momentum, Closing at 32.05 - DWinneX
Should Janux Therapeutics Inc (NASDAQ: JANX) Rally After -123.74% Drop From High? - Marketing Sentinel
Wells Fargo & Company MN Grows Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Are Janux Therapeutics Inc’shares a good deal? - uspostnews.com
Latest Insider moments: Meyer Andrew Hollman, Janux Therapeutics Inc [JANX] Chief Business Officer sold 3,334 shares – Knox Daily - knoxdaily.com
Russell Investments Group Ltd. Buys 442 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Janux Therapeutics Inc (JANX) Worth Considering For The Next Few Weeks - Stocksregister
Legal & General Group Plc Boosts Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - American Banking and Market News
LPL Financial LLC Makes New $439,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Financial Metrics Exploration: Understanding Heron Therapeutics Inc (HRTX) Through Ratios - DWinneX
Cerity Partners LLC Acquires Shares of 4,478 Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Astera Labs, Inc. (NASDAQ:ALAB) Given Average Recommendation of “Buy” by Analysts - Defense World
Janux Therapeutics Inc (JANX)’s stock chart: A technical perspective - uspostnews.com
Janux Therapeutics Inc [JANX] Shares Rise 5.36 % on Wednesday - knoxdaily.com
Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Invesco Ltd. - Defense World
Long Term Trading Analysis for (JANX) - news.stocktradersdaily.com
Geode Capital Management LLC Boosts Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
JPMorgan Chase & Co. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
9,378 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Sei Investments Co. - Defense World
Janux Therapeutics Inc (JANX)’s stock price in review: A technical analysis - uspostnews.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Vanguard Group Inc. - Defense World
Janux Therapeutics stock hits 52-week low at $23.72 By Investing.com - Investing.com South Africa
Janux Therapeutics stock hits 52-week low at $23.72 - Investing.com Australia
Janux Therapeutics: What's My Inflection Point? (NASDAQ:JANX) - Seeking Alpha
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Corebridge Financial Inc. - Defense World
Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout (NASDAQ:JANX) - Seeking Alpha
(JANX) Investment Report - news.stocktradersdaily.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Teacher Retirement System of Texas - Defense World
Janux Therapeutics stock hits 52-week low at $28.92 By Investing.com - Investing.com South Africa
Janux Therapeutics stock hits 52-week low at $28.92 - Investing.com India
Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Insider Monkey
Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March - MSN
We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow - Yahoo Finance
12 Best Up and Coming Stocks to Buy According to Wall Street Analysts - Insider Monkey
First Week of JANX November 21st Options Trading - Nasdaq
RA Capital Management, L.P. Increases Stake in Janux Therapeutics Inc - GuruFocus.com
Charles Schwab Investment Management Inc. Increases Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey
Janux Therapeutics Inc Azioni (JANX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
3.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):